We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




New Imaging Technique Offers Hope for Real-Time Histology

By LabMedica International staff writers
Posted on 13 Dec 2010
Researchers have used a novel microscope-based imaging technique to differentiate between cancer cells and normal cells in living tissue without the need for time-consuming histological procedures.

Investigators at the University of Illinois (Urbana-Champaign, USA) used lipid and protein specific microscopic probes in conjunction with a novel technique called nonlinear interferometric vibrational imaging (NIVI).

The probes were used to label lipid-rich normal cells and protein-rich cancer cells within living rat tissues. More...
By combining two different light sources, the microscope produced colored images that defined normal and cancerous areas within the tissue.

Results published in the November 23, 2010, online edition of the journal Cancer Research revealed that the technique was able to provide easy-to-read, color-coded images of the tissue, with more than 99% confidence, in less than five minutes. Particularly impressive was the technique's ability to outline tumor boundaries clearly.

"Sometimes it is very hard to tell visually whether a cell is normal or abnormal,” said senior author Dr. Stephen A. Boppart, professor of bioengineering and medicine at the University of Illinois. "But molecularly, there are fairly clear signatures.”

"The diagnosis is made based on very subjective interpretation - how the cells are laid out, the structure, the morphology,” said Dr. Boppart. "This is what we call the gold standard for diagnosis. We want to make the process of medical diagnostics more quantitative and more rapid. As we get better spectral resolution and broader spectral range, we can have more flexibility in identifying different molecules. Once you get to that point, we think it will have many different applications for cancer diagnostics, for optical biopsies, and other types of diagnostics.”

Related Links:
University of Illinois




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Silver Member
Fibrinolysis Assay
HemosIL Fibrinolysis Assay Panel
New
Autoimmune Disease Diagnostic
Chorus ds-DNA-G
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.